Sephience 250 mg/1
sepiapterin · POWDER · PTC Therapeutics Inc.
Sepiapterin is an oral powder medication used to treat sepiapterin reductase deficiency, a rare genetic disorder affecting the body's ability to produce certain neurotransmitters. Each dose contains 250 mg of the active ingredient.
Key Facts
- Brand Name
- Sephience
- Generic Name
- sepiapterin
- NDC Code (Product)
52856-201- Manufacturer
- PTC Therapeutics Inc.
- Strength
- 250 mg/1
- Dosage Form
- POWDER
- Route
- ORAL
- Marketing Status
- Application #
- NDA219666
- Marketing Start
- 07/28/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Sephience used for?
Sepiapterin is an oral powder medication used to treat sepiapterin reductase deficiency, a rare genetic disorder affecting the body's ability to produce certain neurotransmitters. Each dose contains 250 mg of the active ingredient.
Is Sephience a controlled substance?
Sephience is not classified as a controlled substance by the DEA.
What is the generic name for Sephience?
The generic name for Sephience is sepiapterin. There are no other listed brand versions of sepiapterin.
What is the NDC code for Sephience 250 mg/1?
The NDC (National Drug Code) for Sephience 250 mg/1 is 52856-201, listed by PTC Therapeutics Inc..
Other Sephience Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)